Intracytoplasmic Sperm Injection Improves Normal Fertilization Rate and Clinical Pregnancy Rate in Male Infertility
Contrast Media & Molecular Imaging · 2022-01 · 2022 (1)
DOI: 10.1155/2022/1522636 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contrast Media & Molecular Imaging, online erschienen am 31.07.2022. Verfasst von Jiqun Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Integrative Medicine Reproduction and Genetics, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Infertility, Male, Sperm Injections, Intracytoplasmic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The purpose of this study was to investigate the effect of intracytoplasmic sperm injection (ICSI) on the normal fertilization rate of oocytes and the clinical pregnancy rate of cycles in male infertility. Eighty cases of male infertility patients attending our hospital from March 2020 to March 2021 were selected and divided into observation group and control group using the random number table method, with 40 cases in each group. The control group was treated with in vitro fertilization (IVF), and the observation group was treated with ICSI. The normal fertilization rate of oocytes and the clinical pregnancy rate of the cycle were compared between the two groups, and the adverse pregnancy outcome and obstetric and perinatal complications were compared between the two groups The rate of normal fertilization and clinical pregnancy in the cycle was higher in the observation group ( P < 0.05). The differences were not statistically significant ( P > 0.05) when comparing adverse pregnancy outcomes between the two groups. The difference was not statistically significant ( P > 0.05) when comparing obstetrics (5.41%, 10.34%) and perinatal complications (8.33%, 14.81%) between the two groups. ICSI in male infertility is significantly effective in improving the rate of normal oocyte fertilization and the clinical pregnancy rate of the cycle. It also has a low impact on adverse pregnancy outcomes and obstetric and perinatal complications and has a high safety profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Integrative Medicine Reproduction and Genetics, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
ORCID-Profile: Xiangyang Lv
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xu, J., Yu, Y., Xue, M., & Lv, X. (2022). Intracytoplasmic Sperm Injection Improves Normal Fertilization Rate and Clinical Pregnancy Rate in Male Infertility. Contrast Media & Molecular Imaging, 2022(1). https://doi.org/10.1155/2022/1522636
Vancouver
Xu J, Yu Y, Xue M, Lv X. Intracytoplasmic Sperm Injection Improves Normal Fertilization Rate and Clinical Pregnancy Rate in Male Infertility. Contrast Media & Molecular Imaging. 2022;2022(1). doi:10.1155/2022/1522636
BibTeX
@article{Xu2022,
author = {Xu, Jiqun and Yu, Yi and Xue, Mingyue and Lv, Xiangyang},
title = {Intracytoplasmic Sperm Injection Improves Normal Fertilization Rate and Clinical Pregnancy Rate in Male Infertility},
journal = {Contrast Media & Molecular Imaging},
year = {2022},
volume = {2022},
number = {1},
doi = {10.1155/2022/1522636}
}
EUVIMED